The Bruckner Group (BGI), a strategy and research firm for the pharmaceutical and biotechnology industries, today announced the results of a large-scale nationwide study on hepatitis C treatment patterns conducted with Brooke Army Medical Center. Select findings are being presented today at the Digestive Disease Week conference in New Orleans.
